Drug price disruption: Will the new Amazon deal have an impact?

A recent analysis by reporter Erin Mershon in STAT  offers five reasons why it is so very difficult to make drugs more affordable, despite President Trump’s repeated vow to lower prices. The five factors are:

Is Putting the Care Back into Healthcare the Answer?

Two recent news articles highlight the fractured nature of our healthcare delivery system. The first article describes how a radioactive isotope (Molybdenum-99 or “moly-99”) that is vital for imaging the bones and the heart is no longer manufactured in the US. We currently rely on sources as far away as South Africa and Australia to supply it. But now there is an ambitious plan to establish production of moly-99 in the cornfields of Wisconsin. A similar story has emerged with the shortage of intravenous saline (salt) solutions needed in the treatment of the current flu epidemic. The main source has been Puerto Rico, which suffered serious damage from Hurricane Maria and is no longer able to export its goods.